The Case for Measuring Everything: Why Data-Driven Medicine Produces Better Outcomes

Most medical care is reactive. A symptom appears. A test is ordered. A diagnosis is made. A treatment is prescribed. The cycle repeats.

This model works well for acute illness. It works poorly for the slow, multisystem decline that characterizes aging. By the time symptoms drive a patient to seek care, the underlying dysfunction has often been progressing for years.

A different model measures proactively, comprehensively, and longitudinally. It identifies dysfunction before symptoms appear, quantifies the response to intervention, and tracks the trajectory of health across decades rather than visits.

Why Measurement Matters

Symptoms Are Late Indicators

A man does not feel his coronary arteries narrowing. A woman does not feel her bone density declining. Insulin resistance produces no sensation until the pancreas begins to fail. Testosterone declines at 1 to 2 percent per year, which means the loss is imperceptible on any given day but cumulative over a decade.

By the time symptoms appear, the underlying process is often advanced. Fatigue from low testosterone means levels have been declining for years. Weight gain from insulin resistance means the metabolic dysfunction has been building for a decade. Bone fracture from osteoporosis means bone density has been eroding since menopause.

Measurement catches these processes in their early phases, when intervention is most effective and least invasive.

Objectivity Eliminates Guesswork

A patient who reports “feeling better” on testosterone therapy provides useful but subjective information. A patient whose free testosterone has risen from 220 to 450 pmol/L, whose fasting insulin has dropped from 14 to 6 µIU/mL, whose hematocrit remains at 48%, and who reports improved sleep, energy, and exercise tolerance provides a multidimensional clinical picture that confirms the treatment is working and is safe.

Objectivity also protects against the placebo effect, confirmation bias, and the natural fluctuations in how people feel day to day. The blood work does not have good days and bad days. It reports what is.

Trends Are More Informative Than Snapshots

A single blood draw is a photograph. A series of blood draws over months and years is a film. The trajectory of a marker over time reveals patterns that a single measurement cannot.

A man whose hematocrit is 49% at one draw may be fine. A man whose hematocrit has risen from 44% to 47% to 49% over three consecutive draws is on a trajectory that requires attention, even though each individual value is within the reference range.

Consider HbA1c again: a woman whose HbA1c is 5.3% in isolation may be considered metabolically healthy. But a woman whose HbA1c has risen from 4.8% to 5.0% to 5.3% over three years is moving in the wrong direction, and this trajectory demands intervention before a single snapshot would justify treatment. More revealing still: a woman with stable HbA1c but fasting insulin rising from 8 to 12 to 16 µIU/mL is developing insulin resistance silently, detectable only through longitudinal data. The snapshot lies dormant; the trend screams warning.

The Three Domains

Comprehensive measurement requires capturing multiple dimensions of health simultaneously. A blood test alone does not tell you how the patient feels. A symptom questionnaire alone does not tell you what the blood shows. A fitness assessment alone does not reveal the metabolic environment.

At Manus Solis, the Vis Viva framework organizes measurement into three domains:

Sensus: The Felt Experience

Standardized symptom assessment captures energy, sleep quality, mood stability, cognitive clarity, libido, joint pain, and overall quality of life. These are scored numerically at each visit, creating a longitudinal record of the patient’s subjective health.

Sensus captures what no lab test can: how the patient experiences their own body. A testosterone level of 22 nmol/L means nothing in isolation. A testosterone level of 22 nmol/L in a man who rates his energy at 8/10, sleeps 7.5 hours nightly, and reports clear cognition means the treatment is working. The same level in a man who still rates his energy at 4/10 and reports persistent fog means the protocol needs adjustment despite acceptable blood work.

Pulsus: The Biological Signal

Comprehensive blood work, including hormonal markers, metabolic panels, inflammatory indices, hematological parameters, thyroid function, and nutritional status, provides the biological data layer.

Pulsus is where early dysfunction is detected, where treatment response is confirmed, and where safety is monitored. This is particularly crucial for metabolic health. A single HbA1c reading, for example, offers only a coarse three-month average and can be distorted by factors entirely unrelated to glucose control—iron status, red blood cell lifespan, even genetic hemoglobin variants can shift HbA1c substantially without any change in actual blood glucose. A patient with a normal HbA1c but elevated fasting insulin, or normal fasting glucose paired with a sharp postprandial glucose spike, reveals metabolic dysfunction that HbA1c alone would miss entirely. Pulsus captures the full biological picture by triangulating multiple markers, enabling intervention before disease becomes symptomatic.

Virtus: The Body in Motion

Physical capacity testing, including VO2 max, grip strength, body composition (DEXA or bioimpedance), and wearable data (HRV, resting heart rate, sleep staging), measures what the body can actually do.

Virtus captures functional health. The composition of body mass itself—the ratio of fat to lean muscle—predicts health and mortality more accurately than weight or BMI alone. Lean muscle mass is inversely associated with mortality; men and women with greater grip strength show a 31% reduction in all-cause mortality compared to those with lower strength. Conversely, visceral fat—fat accumulated around internal organs—creates a specific metabolic burden that subcutaneous fat does not, driving inflammation and metabolic dysfunction independent of overall weight. A man with excellent blood work who cannot climb two flights of stairs without becoming winded has a fitness problem that blood work alone would not reveal. A woman whose body composition is shifting toward visceral fat accumulation despite weight stability may be moving toward metabolic disease that standard metrics would not capture.

How the Domains Interact

The power of three-domain measurement is not in any single domain but in their convergence.

When all three domains improve in parallel, the clinical picture is coherent and the treatment is validated. When one domain lags, it identifies exactly where the protocol needs adjustment.

A patient whose Pulsus markers are improving (falling fasting insulin, rising free testosterone) but whose Sensus is unchanged (persistent fatigue, poor sleep) needs investigation into factors outside the hormonal and metabolic panel: sleep disorders, stress, nutritional deficiency, or medication interference.

A patient whose Sensus is excellent (feels great) but whose Pulsus shows rising hematocrit or worsening lipids needs a dose adjustment that their subjective experience would not have prompted.

A patient whose Pulsus and Sensus are both improving but whose Virtus is flat (no change in VO2 max or body composition) may need an exercise prescription adjustment or may have a training stimulus that is insufficient for the hormonal environment to act upon.

Each domain checks the others. The result is a clinical picture with three independent sources of verification, reducing the chance that a significant issue is missed.

Longitudinal Commitment

Measurement is not a one-time event. The value compounds over time. A patient with 18 months of longitudinal Vis Viva data has a health trajectory that is visible, interpretable, and actionable in ways that a single visit cannot achieve.

Longitudinal data reveals which interventions produced results, which need adjustment, and how the patient’s health is trending relative to their own baseline and to population norms for their age.

This is the clinical model that longevity medicine requires. The goal is not to treat disease after it appears. The goal is to maintain function, identify decline early, and intervene while the window for full restoration is open.

The Investment

Comprehensive measurement requires more blood draws, more data collection, and more physician time than a standard annual physical. The investment is real, in time and in cost.

The return is a level of clinical insight that standard care does not provide. It is the difference between knowing you are “fine” and knowing, with precision, where you stand, where you are heading, and what to do about it.

Continue Reading

If you found this useful, these related articles may deepen your understanding:

• VO2 Max: The Single Best Predictor of Longevity
• HRV, Wearables, and Hormones
• How to Read Your Blood Work

---

Dr. Handsun Xiao is a McGill trained physician (MD, CCFP) practicing functional medicine and bioidentical hormone therapy in Toronto, with virtual consultations available to patients across Ontario. He holds advanced BHRT certification through WorldLink Medical and IFM AFMCP training. Manus Solis offers physician led BHRT consultations with custom compounding through a dedicated Ontario pharmacy partner. To learn more or book a virtual consultation, visit manussolis.ca.